|
|
Article: Findings from Laval University in monoclonal antibodies reported.
- Article from:
- Biotech Week
- Article date:
- February 25, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
"The study and therapeutic modulation of purinergic signaling is hindered by a lack of specific inhibitors for NTP diphosphohydrolases (NTPDases), which are the terminating enzymes for these processes. In addition, little is known of the NTPDase protein structural elements that affect enzymatic activity and which could be used as targets for inhibitor design," investigators in Canada report (see also Monoclonal Antibodies).
"In the present study, we report the first inhibitory monoclonal antibodies specific for an NTPDase, namely human NTPDase3 (EC 3.6.1.5), as assessed by ELISA, western blotting, flow cytometry, immunohistochemistry and inhibition assays. ...
Related newspaper, magazine, and journal articles:
|
|
Article: Laval University publishes research in ...
Biotech Week;
November 4, 2009 ;
700+ words
... ... B.J. Mcfadyen and colleagues, Laval University (see also Rehabilitation Research ... information, contact B.J. Mcfadyen, Laval University, Center Interdisciplinary Research ... Canada, Rehabilitation Research, Laval University. This article was prepared by Biotech ...
|
|